Purpose.—To develop a guideline to improve the accuracy of immunohistochemical (IHC)
estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the …

Background.—Under the auspices of the College of American Pathologists, a multidisciplinary
group of clinicians, pathologists, and statisticians considered prognostic and predictive …

Introduction of tumor markers into routine clinical practice has been poorly controlled, with
few criteria or guidelines as to how such markers should be used. We propose a Tumor …

… % of the invasive tumor cells d or complete and circumferential … d or membrane staining
that is incomplete and is faint/barely perceptible and within ≤ 10% of the invasive tumor cells d …

Unsupervised class discovery is a highly useful technique in cancer research, where
intrinsic groups sharing biological characteristics may exist but are unknown. The consensus …

Purpose To develop a guideline to improve the accuracy of human epidermal growth factor
receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. …

Background We tested the hypothesis that the level of circulating tumor cells can predict
survival in metastatic breast cancer. Methods In a prospective, multicenter study, we tested 177 …

Background The status of human epidermal growth factor receptor type 2 (HER2) in breast-cancer
cells predicts clinical outcomes in women who receive adjuvant anthracycline-based …

The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in
glioblastoma multiforme (GBM). We describe a robust gene expression-based molecular …

Uncontrolled proliferation is a hallmark of cancer. In breast cancer, immunohistochemical
assessment of the proportion of cells staining for the nuclear antigen Ki67 has become the …